Biochemistry, Genetics and Molecular Biology
Tumor Progression
100%
Angiogenesis
100%
Target Cell
100%
Fibronectin
100%
Fibroblast
100%
Gene Expression
50%
Small Interfering RNA
50%
Isoform
50%
Downregulation
50%
Normal Human
50%
Survival Factor
50%
Alternative Splicing
50%
Fetus Development
50%
Stromal Cell
50%
Transforming Growth Factor Beta
50%
TGF Beta 1
50%
Neutralizing Antibody
50%
Epigenetic Mechanism
50%
Keyphrases
Tumor Progression
100%
Angiogenesis
100%
Stimulating Factor
100%
Clinical Intervention
100%
Fibronectin
18%
Pharmacological Agents
18%
Cancer Patients
18%
In Cancer
9%
Gene Expression
9%
Fibroblasts
9%
Migration Invasion
9%
Healthy Adults
9%
Small Interfering RNA (siRNA)
9%
Epithelial Cells
9%
Regulatory Molecules
9%
Endothelium
9%
Neutralizing Antibodies
9%
Oral Cancer
9%
Patients with Cancer
9%
Survival Factor
9%
Alternative Splicing
9%
Angiogenic
9%
Bioactivity
9%
Fetal Development
9%
Soluble Factors
9%
Stromal Cells
9%
Matrix Molecules
9%
Truncated Isoform
9%
Patients with Breast Cancer
9%
Treatment Outcome
9%
Poor Survival
9%
Fetal Patient
9%
Transforming Growth Factor-β
9%
Oncofetal
9%
Dermal Fibroblasts
9%
Patient Cells
9%
Transforming Growth factor-β1 (TGF-β1)
9%
Matrix Remodeling
9%
Epigenetic Mechanisms
9%
Factor Effects
9%
Factor Inhibitors
9%
Medicine and Dentistry
Angiogenesis
100%
Tumor Progression
100%
Migration Stimulating Factor
100%
Clinical Intervention
100%
Malignant Neoplasm
18%
Fibronectin
18%
Target Cell
18%
Fibroblast
18%
Breast Cancer
9%
Gene Expression
9%
Epithelial Cell
9%
Prematurity
9%
Oral Cancer
9%
Fetus Development
9%
Small Interfering RNA
9%
Adherent Cell
9%
Stromal Cell
9%
Survival Factor
9%
Downregulation
9%
Transforming Growth Factor Beta
9%
Transforming Growth Factor Beta1
9%
Alternative RNA Splicing
9%
Neutralizing Antibody
9%
Epigenetic Mechanism
9%
Immunology and Microbiology
Angiogenesis
100%
Migration Stimulating Factor
100%
Target Cell
18%
Fibronectin
18%
Fibroblast
18%
Gene Expression
9%
Downregulation
9%
Neutralizing Antibody
9%
Normal Human
9%
Survival Factor
9%
Alternative RNA Splicing
9%
Fetus Development
9%
Adherent Cell
9%
Transforming Growth Factor Beta
9%
Transforming Growth Factor Beta1
9%
Epigenetic Mechanism
9%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Growth
100%
Migration Stimulating Factor
100%
Malignant Neoplasm
27%
Fibronectin
18%
Breast Cancer
9%
Small Interfering RNA
9%
Prematurity
9%
Mouth Cancer
9%
Normal Human
9%
Transforming Growth Factor Beta
9%
Survival Factor
9%
Transforming Growth Factor Beta1
9%
Neutralizing Antibody
9%